Contact
Please use this form to send email to PR contact of this press release:
Prapela’s FDA-Authorized Groundbreaking Therapy for Opioid-Exposed Infants Highlighted at Washington DC Showcase Event
TO:
John P Konsin
Prapela, Inc.
+1 833-772-7352